From GlobeNewswire: 2025-03-06 17:01:00

Nova Leap Health Corp. released its financial results for the year ended December 31, 2024, with a record Adjusted EBITDA of $1,561,761, a 5.7% increase over 2023. Operating income for 2024 was $863,712, an 87.7% increase over 2023. Annual revenues decreased 1.6% to $25.761 million, with a net income of $886,268 in Q4 2024.

In Q4 2024, Nova Leap Health Corp. recorded a net income of $886,268, a significant improvement from a net loss of $206,871 in Q3 2024. The company had cash and cash equivalents of $1,402,767 as of December 31, 2024, with total demand loans and promissory notes outstanding of $1,664,067, representing a leverage ratio of 1.07 times 2024 Adjusted EBITDA.

Business acquisitions and financing activities included the acquisition of home care businesses in Massachusetts, Florida, and Nova Scotia. Nova Leap Health Corp. also amended its credit agreement to provide up to an additional $7,000,000 of available credit for future acquisitions. The company’s geographical operations span 10 U.S. states and Nova Scotia, Canada, focusing on home health care services.

Adjusted EBITDA, a key financial measure, increased to $412,947 in Q4 2024, reflecting growth and financial stability. The company’s performance aligns with its strategic growth plans, including cost savings, acquisitions, and business expansion. Nova Leap Health Corp. maintains a strong position in the home health care industry, emphasizing individual and family-centered care.



Read more at GlobeNewswire:: Nova Leap Health Corp. Posts Fourth Quarter and 2024 Annual